p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice Article Swipe
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1111/bph.14035
Background and Purpose The tumour suppressor p53 is traditionally recognized as a surveillance molecule to preserve genome integrity. Recent studies have demonstrated that it contributes to metabolic diseases. Here, we investigated the role of p53 in the regulation of bile acid disposition and cholestasis. Experimental Approach The bile acid disposition‐related gene expression profile affected by p53 activation was assessed in mouse primary hepatocytes with p53 depletion and in Trp53 ‐null mice. Dual luciferase reporter assay was used to detect the transcriptional activities of target genes. Anticholestatic effects of p53 activator doxorubicin were investigated in a 0.5% cholic acid‐fed mouse model of cholestasis. Changes in bile acids were evaluated using metabolomics analysis. Key Results Doxorubicin‐mediated p53 activation induced Cyp2b10 , Sult2a1 and Abcc2/3/4 expression in mice in vitro and in vivo . ABCC3 and CYP2B6 (human orthologue of Cyp2b10 ) were identified as direct p53 target genes. Doxorubicin attenuated cholic acid‐induced cholestasis in mice, as demonstrated by shrunken gall bladder, decreased serum total bile acid and total bilirubin levels and alkaline phosphatase activity. Targeted metabolomics analysis revealed that doxorubicin enhanced the excretion of bile acid metabolites from serum and liver to intestine and faeces. Up‐regulation of Cyp2b10 , Sult2a1 and Abcc2/3/4 expression was further confirmed in cholestatic mice. Cholic acid‐induced cholestatic injury was aggravated in p53‐deficient mice and levels of bile acid in intestine and faeces were decreased. Conclusions and Implications Our findings suggest a novel role of p53 in promoting bile acid disposition and alleviating cholestatic syndrome, which provides a potential therapeutic target for cholestasis.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1111/bph.14035
- https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035
- OA Status
- bronze
- Cited By
- 23
- References
- 54
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2756280784
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2756280784Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/bph.14035Digital Object Identifier
- Title
-
p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in miceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-09-14Full publication date if available
- Authors
-
Pan Chen, Dongshun Li, Yixin Chen, Jiahong Sun, Kaili Fu, Lihuan Guan, Huizhen Zhang, Yiming Jiang, Xi Li, Xuezhen Zeng, Xiao Chen, Min Huang, Huichang BiList of authors in order
- Landing page
-
https://doi.org/10.1111/bph.14035Publisher landing page
- PDF URL
-
https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035Direct OA link when available
- Concepts
-
Cholic acid, Cholestasis, Bile acid, Lithocholic acid, Chenodeoxycholic acid, Cholesterol 7 alpha-hydroxylase, Internal medicine, Taurocholic acid, Biology, Endocrinology, Multidrug resistance-associated protein 2, Biochemistry, Chemistry, Medicine, ATP-binding cassette transporter, Gene, TransporterTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
23Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 3, 2023: 3, 2022: 2, 2021: 3Per-year citation counts (last 5 years)
- References (count)
-
54Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2756280784 |
|---|---|
| doi | https://doi.org/10.1111/bph.14035 |
| ids.doi | https://doi.org/10.1111/bph.14035 |
| ids.mag | 2756280784 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28910492 |
| ids.openalex | https://openalex.org/W2756280784 |
| fwci | 1.27460005 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | Q000494 |
| mesh[1].descriptor_ui | D000970 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | pharmacology |
| mesh[1].descriptor_name | Antineoplastic Agents |
| mesh[2].qualifier_ui | Q000235 |
| mesh[2].descriptor_ui | D001189 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | genetics |
| mesh[2].descriptor_name | Aryl Hydrocarbon Hydroxylases |
| mesh[3].qualifier_ui | Q000378 |
| mesh[3].descriptor_ui | D001647 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | metabolism |
| mesh[3].descriptor_name | Bile Acids and Salts |
| mesh[4].qualifier_ui | Q000235 |
| mesh[4].descriptor_ui | D002779 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | genetics |
| mesh[4].descriptor_name | Cholestasis |
| mesh[5].qualifier_ui | Q000503 |
| mesh[5].descriptor_ui | D002779 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | physiopathology |
| mesh[5].descriptor_name | Cholestasis |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D019826 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Cholic Acid |
| mesh[7].qualifier_ui | Q000235 |
| mesh[7].descriptor_ui | D000072467 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | genetics |
| mesh[7].descriptor_name | Cytochrome P450 Family 2 |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D004195 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Disease Models, Animal |
| mesh[9].qualifier_ui | Q000494 |
| mesh[9].descriptor_ui | D004317 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pharmacology |
| mesh[9].descriptor_name | Doxorubicin |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000378 |
| mesh[11].descriptor_ui | D008099 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | metabolism |
| mesh[11].descriptor_name | Liver |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D008297 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Male |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D051379 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Mice |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008810 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Mice, Inbred C57BL |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D018345 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Mice, Knockout |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000089762 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Multidrug Resistance-Associated Protein 2 |
| mesh[17].qualifier_ui | Q000235 |
| mesh[17].descriptor_ui | D027425 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | genetics |
| mesh[17].descriptor_name | Multidrug Resistance-Associated Proteins |
| mesh[18].qualifier_ui | Q000235 |
| mesh[18].descriptor_ui | D013250 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | genetics |
| mesh[18].descriptor_name | Steroid Hydroxylases |
| mesh[19].qualifier_ui | Q000235 |
| mesh[19].descriptor_ui | D015238 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | genetics |
| mesh[19].descriptor_name | Sulfotransferases |
| mesh[20].qualifier_ui | Q000235 |
| mesh[20].descriptor_ui | D016159 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | genetics |
| mesh[20].descriptor_name | Tumor Suppressor Protein p53 |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D015854 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Up-Regulation |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000818 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Animals |
| mesh[23].qualifier_ui | Q000494 |
| mesh[23].descriptor_ui | D000970 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | pharmacology |
| mesh[23].descriptor_name | Antineoplastic Agents |
| mesh[24].qualifier_ui | Q000235 |
| mesh[24].descriptor_ui | D001189 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | genetics |
| mesh[24].descriptor_name | Aryl Hydrocarbon Hydroxylases |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D001647 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Bile Acids and Salts |
| mesh[26].qualifier_ui | Q000235 |
| mesh[26].descriptor_ui | D002779 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | genetics |
| mesh[26].descriptor_name | Cholestasis |
| mesh[27].qualifier_ui | Q000503 |
| mesh[27].descriptor_ui | D002779 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | physiopathology |
| mesh[27].descriptor_name | Cholestasis |
| mesh[28].qualifier_ui | Q000008 |
| mesh[28].descriptor_ui | D019826 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | administration & dosage |
| mesh[28].descriptor_name | Cholic Acid |
| mesh[29].qualifier_ui | Q000235 |
| mesh[29].descriptor_ui | D000072467 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | genetics |
| mesh[29].descriptor_name | Cytochrome P450 Family 2 |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D004195 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Disease Models, Animal |
| mesh[31].qualifier_ui | Q000494 |
| mesh[31].descriptor_ui | D004317 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | pharmacology |
| mesh[31].descriptor_name | Doxorubicin |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D006801 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Humans |
| mesh[33].qualifier_ui | Q000378 |
| mesh[33].descriptor_ui | D008099 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | metabolism |
| mesh[33].descriptor_name | Liver |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D008297 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Male |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D051379 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Mice |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D008810 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Mice, Inbred C57BL |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D018345 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Mice, Knockout |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D000089762 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Multidrug Resistance-Associated Protein 2 |
| mesh[39].qualifier_ui | Q000235 |
| mesh[39].descriptor_ui | D027425 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | genetics |
| mesh[39].descriptor_name | Multidrug Resistance-Associated Proteins |
| mesh[40].qualifier_ui | Q000235 |
| mesh[40].descriptor_ui | D013250 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | genetics |
| mesh[40].descriptor_name | Steroid Hydroxylases |
| mesh[41].qualifier_ui | Q000235 |
| mesh[41].descriptor_ui | D015238 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | genetics |
| mesh[41].descriptor_name | Sulfotransferases |
| mesh[42].qualifier_ui | Q000235 |
| mesh[42].descriptor_ui | D016159 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | genetics |
| mesh[42].descriptor_name | Tumor Suppressor Protein p53 |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D015854 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Up-Regulation |
| type | article |
| title | p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice |
| awards[0].id | https://openalex.org/G2441325502 |
| awards[0].funder_id | https://openalex.org/F4320321001 |
| awards[0].display_name | |
| awards[0].funder_award_id | 81573489 |
| awards[0].funder_display_name | National Natural Science Foundation of China |
| awards[1].id | https://openalex.org/G5273174581 |
| awards[1].funder_id | https://openalex.org/F4320321001 |
| awards[1].display_name | |
| awards[1].funder_award_id | 81320108027 |
| awards[1].funder_display_name | National Natural Science Foundation of China |
| awards[2].id | https://openalex.org/G7043644890 |
| awards[2].funder_id | https://openalex.org/F4320321001 |
| awards[2].display_name | |
| awards[2].funder_award_id | 81522047 |
| awards[2].funder_display_name | National Natural Science Foundation of China |
| awards[3].id | https://openalex.org/G6978141539 |
| awards[3].funder_id | https://openalex.org/F4320321001 |
| awards[3].display_name | |
| awards[3].funder_award_id | 81373470 |
| awards[3].funder_display_name | National Natural Science Foundation of China |
| awards[4].id | https://openalex.org/G8402840893 |
| awards[4].funder_id | https://openalex.org/F4320321001 |
| awards[4].display_name | |
| awards[4].funder_award_id | 81503156 |
| awards[4].funder_display_name | National Natural Science Foundation of China |
| biblio.issue | 23 |
| biblio.volume | 174 |
| biblio.last_page | 4361 |
| biblio.first_page | 4345 |
| topics[0].id | https://openalex.org/T10570 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Drug Transport and Resistance Mechanisms |
| topics[1].id | https://openalex.org/T12460 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9987999796867371 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Pediatric Hepatobiliary Diseases and Treatments |
| topics[2].id | https://openalex.org/T10340 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9976000189781189 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Hepatitis B Virus Studies |
| funders[0].id | https://openalex.org/F4320321001 |
| funders[0].ror | https://ror.org/01h0zpd94 |
| funders[0].display_name | National Natural Science Foundation of China |
| is_xpac | False |
| apc_list.value | 4330 |
| apc_list.currency | USD |
| apc_list.value_usd | 4330 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2775900799 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8490754961967468 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q287415 |
| concepts[0].display_name | Cholic acid |
| concepts[1].id | https://openalex.org/C2778593092 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7497128248214722 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1075923 |
| concepts[1].display_name | Cholestasis |
| concepts[2].id | https://openalex.org/C2779399885 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7435795068740845 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q413288 |
| concepts[2].display_name | Bile acid |
| concepts[3].id | https://openalex.org/C2780420665 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5353994965553284 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3323035 |
| concepts[3].display_name | Lithocholic acid |
| concepts[4].id | https://openalex.org/C2781089062 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5105019807815552 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q419028 |
| concepts[4].display_name | Chenodeoxycholic acid |
| concepts[5].id | https://openalex.org/C89673097 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4865185618400574 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q14907373 |
| concepts[5].display_name | Cholesterol 7 alpha-hydroxylase |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.47725674510002136 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C2780480987 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4638723134994507 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2659931 |
| concepts[7].display_name | Taurocholic acid |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.4609750807285309 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C134018914 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4289950430393219 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[9].display_name | Endocrinology |
| concepts[10].id | https://openalex.org/C36201501 |
| concepts[10].level | 5 |
| concepts[10].score | 0.42863765358924866 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q17907816 |
| concepts[10].display_name | Multidrug resistance-associated protein 2 |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.35914838314056396 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C185592680 |
| concepts[12].level | 0 |
| concepts[12].score | 0.3282766342163086 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[12].display_name | Chemistry |
| concepts[13].id | https://openalex.org/C71924100 |
| concepts[13].level | 0 |
| concepts[13].score | 0.19843387603759766 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[13].display_name | Medicine |
| concepts[14].id | https://openalex.org/C44312359 |
| concepts[14].level | 4 |
| concepts[14].score | 0.10701510310173035 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q286958 |
| concepts[14].display_name | ATP-binding cassette transporter |
| concepts[15].id | https://openalex.org/C104317684 |
| concepts[15].level | 2 |
| concepts[15].score | 0.09177634119987488 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[15].display_name | Gene |
| concepts[16].id | https://openalex.org/C149011108 |
| concepts[16].level | 3 |
| concepts[16].score | 0.09121963381767273 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q652985 |
| concepts[16].display_name | Transporter |
| keywords[0].id | https://openalex.org/keywords/cholic-acid |
| keywords[0].score | 0.8490754961967468 |
| keywords[0].display_name | Cholic acid |
| keywords[1].id | https://openalex.org/keywords/cholestasis |
| keywords[1].score | 0.7497128248214722 |
| keywords[1].display_name | Cholestasis |
| keywords[2].id | https://openalex.org/keywords/bile-acid |
| keywords[2].score | 0.7435795068740845 |
| keywords[2].display_name | Bile acid |
| keywords[3].id | https://openalex.org/keywords/lithocholic-acid |
| keywords[3].score | 0.5353994965553284 |
| keywords[3].display_name | Lithocholic acid |
| keywords[4].id | https://openalex.org/keywords/chenodeoxycholic-acid |
| keywords[4].score | 0.5105019807815552 |
| keywords[4].display_name | Chenodeoxycholic acid |
| keywords[5].id | https://openalex.org/keywords/cholesterol-7-alpha-hydroxylase |
| keywords[5].score | 0.4865185618400574 |
| keywords[5].display_name | Cholesterol 7 alpha-hydroxylase |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.47725674510002136 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/taurocholic-acid |
| keywords[7].score | 0.4638723134994507 |
| keywords[7].display_name | Taurocholic acid |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.4609750807285309 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/endocrinology |
| keywords[9].score | 0.4289950430393219 |
| keywords[9].display_name | Endocrinology |
| keywords[10].id | https://openalex.org/keywords/multidrug-resistance-associated-protein-2 |
| keywords[10].score | 0.42863765358924866 |
| keywords[10].display_name | Multidrug resistance-associated protein 2 |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.35914838314056396 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/chemistry |
| keywords[12].score | 0.3282766342163086 |
| keywords[12].display_name | Chemistry |
| keywords[13].id | https://openalex.org/keywords/medicine |
| keywords[13].score | 0.19843387603759766 |
| keywords[13].display_name | Medicine |
| keywords[14].id | https://openalex.org/keywords/atp-binding-cassette-transporter |
| keywords[14].score | 0.10701510310173035 |
| keywords[14].display_name | ATP-binding cassette transporter |
| keywords[15].id | https://openalex.org/keywords/gene |
| keywords[15].score | 0.09177634119987488 |
| keywords[15].display_name | Gene |
| keywords[16].id | https://openalex.org/keywords/transporter |
| keywords[16].score | 0.09121963381767273 |
| keywords[16].display_name | Transporter |
| language | en |
| locations[0].id | doi:10.1111/bph.14035 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S55107261 |
| locations[0].source.issn | 0007-1188, 1476-5381 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0007-1188 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | British Journal of Pharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | |
| locations[0].pdf_url | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | British Journal of Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.1111/bph.14035 |
| locations[1].id | pmid:28910492 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | British journal of pharmacology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28910492 |
| locations[2].id | pmh:oai:europepmc.org:5233461 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC5715589 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:5715589 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Br J Pharmacol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5715589 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5100435226 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0271-2725 |
| authorships[0].author.display_name | Pan Chen |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I157773358, https://openalex.org/I4210128921 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacy The First Affiliated Hospital of Sun Yat-sen University Guangzhou China |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I157773358 |
| authorships[0].affiliations[1].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[0].institutions[0].id | https://openalex.org/I157773358 |
| authorships[0].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Sun Yat-sen University |
| authorships[0].institutions[1].id | https://openalex.org/I4210128921 |
| authorships[0].institutions[1].ror | https://ror.org/037p24858 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210128921 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | The First Affiliated Hospital, Sun Yat-sen University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Pan Chen |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Pharmacy The First Affiliated Hospital of Sun Yat-sen University Guangzhou China, School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[1].author.id | https://openalex.org/A5015125917 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Dongshun Li |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[1].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[1].institutions[0].id | https://openalex.org/I157773358 |
| authorships[1].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Sun Yat-sen University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Dongshun Li |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[2].author.id | https://openalex.org/A5100393441 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7701-4687 |
| authorships[2].author.display_name | Yixin Chen |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[2].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[2].institutions[0].id | https://openalex.org/I157773358 |
| authorships[2].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Sun Yat-sen University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yixin Chen |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[3].author.id | https://openalex.org/A5083245275 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Jiahong Sun |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[3].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[3].institutions[0].id | https://openalex.org/I157773358 |
| authorships[3].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Sun Yat-sen University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jiahong Sun |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[4].author.id | https://openalex.org/A5068145080 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Kaili Fu |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[4].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[4].institutions[0].id | https://openalex.org/I157773358 |
| authorships[4].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Sun Yat-sen University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kaili Fu |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[5].author.id | https://openalex.org/A5062586202 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Lihuan Guan |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[5].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[5].institutions[0].id | https://openalex.org/I157773358 |
| authorships[5].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Sun Yat-sen University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lihuan Guan |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[6].author.id | https://openalex.org/A5100663357 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-7253-9740 |
| authorships[6].author.display_name | Huizhen Zhang |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[6].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[6].institutions[0].id | https://openalex.org/I157773358 |
| authorships[6].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Sun Yat-sen University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Huizhen Zhang |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[7].author.id | https://openalex.org/A5088331911 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4894-177X |
| authorships[7].author.display_name | Yiming Jiang |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[7].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[7].institutions[0].id | https://openalex.org/I157773358 |
| authorships[7].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Sun Yat-sen University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Yiming Jiang |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[8].author.id | https://openalex.org/A5100407704 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7106-1677 |
| authorships[8].author.display_name | Xi Li |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[8].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[8].institutions[0].id | https://openalex.org/I157773358 |
| authorships[8].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Sun Yat-sen University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Xi Li |
| authorships[8].is_corresponding | True |
| authorships[8].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[9].author.id | https://openalex.org/A5056200578 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0241-6144 |
| authorships[9].author.display_name | Xuezhen Zeng |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[9].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[9].institutions[0].id | https://openalex.org/I157773358 |
| authorships[9].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Sun Yat-sen University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Xuezhen Zeng |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[10].author.id | https://openalex.org/A5100373743 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9476-812X |
| authorships[10].author.display_name | Xiao Chen |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I157773358, https://openalex.org/I4210128921 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Pharmacy The First Affiliated Hospital of Sun Yat-sen University Guangzhou China |
| authorships[10].institutions[0].id | https://openalex.org/I157773358 |
| authorships[10].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | Sun Yat-sen University |
| authorships[10].institutions[1].id | https://openalex.org/I4210128921 |
| authorships[10].institutions[1].ror | https://ror.org/037p24858 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210128921 |
| authorships[10].institutions[1].country_code | CN |
| authorships[10].institutions[1].display_name | The First Affiliated Hospital, Sun Yat-sen University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Xiao Chen |
| authorships[10].is_corresponding | True |
| authorships[10].raw_affiliation_strings | Department of Pharmacy The First Affiliated Hospital of Sun Yat-sen University Guangzhou China |
| authorships[11].author.id | https://openalex.org/A5100655503 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2844-5680 |
| authorships[11].author.display_name | Min Huang |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[11].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[11].institutions[0].id | https://openalex.org/I157773358 |
| authorships[11].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Sun Yat-sen University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Min Huang |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[12].author.id | https://openalex.org/A5020183416 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-7094-2296 |
| authorships[12].author.display_name | Huichang Bi |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I157773358 |
| authorships[12].affiliations[0].raw_affiliation_string | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| authorships[12].institutions[0].id | https://openalex.org/I157773358 |
| authorships[12].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Sun Yat-sen University |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Huichang Bi |
| authorships[12].is_corresponding | True |
| authorships[12].raw_affiliation_strings | School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10570 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Drug Transport and Resistance Mechanisms |
| related_works | https://openalex.org/W2089205235, https://openalex.org/W2414830212, https://openalex.org/W1982685080, https://openalex.org/W1989011030, https://openalex.org/W2065946335, https://openalex.org/W2018093312, https://openalex.org/W2040868134, https://openalex.org/W2436685606, https://openalex.org/W2414824292, https://openalex.org/W1493101328 |
| cited_by_count | 23 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 3 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 4 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 3 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1111/bph.14035 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S55107261 |
| best_oa_location.source.issn | 0007-1188, 1476-5381 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0007-1188 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | British Journal of Pharmacology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | British Journal of Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.1111/bph.14035 |
| primary_location.id | doi:10.1111/bph.14035 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S55107261 |
| primary_location.source.issn | 0007-1188, 1476-5381 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0007-1188 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | British Journal of Pharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | |
| primary_location.pdf_url | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14035 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | British Journal of Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.1111/bph.14035 |
| publication_date | 2017-09-14 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2196064518, https://openalex.org/W2191824243, https://openalex.org/W1988871942, https://openalex.org/W2119239003, https://openalex.org/W2139000389, https://openalex.org/W2018314238, https://openalex.org/W3111405559, https://openalex.org/W1119423221, https://openalex.org/W2155864743, https://openalex.org/W1963796469, https://openalex.org/W1596457615, https://openalex.org/W2034106555, https://openalex.org/W1989027116, https://openalex.org/W2021938834, https://openalex.org/W2009096172, https://openalex.org/W2134344683, https://openalex.org/W1539913287, https://openalex.org/W2015625368, https://openalex.org/W2038652783, https://openalex.org/W1526415700, https://openalex.org/W2029000257, https://openalex.org/W2593755768, https://openalex.org/W1593555249, https://openalex.org/W2075515706, https://openalex.org/W2051988120, https://openalex.org/W1966163762, https://openalex.org/W2021206718, https://openalex.org/W2053581007, https://openalex.org/W2062515127, https://openalex.org/W1888470382, https://openalex.org/W2138620717, https://openalex.org/W2019695487, https://openalex.org/W2117969095, https://openalex.org/W2133373613, https://openalex.org/W2194756172, https://openalex.org/W2092288031, https://openalex.org/W2083659501, https://openalex.org/W1902431806, https://openalex.org/W2002121467, https://openalex.org/W4293201222, https://openalex.org/W1985641799, https://openalex.org/W1801077835, https://openalex.org/W2097933346, https://openalex.org/W2044732314, https://openalex.org/W2141320958, https://openalex.org/W4294446350, https://openalex.org/W2026160870, https://openalex.org/W2070024353, https://openalex.org/W2128687987, https://openalex.org/W1812358095, https://openalex.org/W2127953736, https://openalex.org/W1860026848, https://openalex.org/W1966916675, https://openalex.org/W2001306967 |
| referenced_works_count | 54 |
| abstract_inverted_index.) | 138 |
| abstract_inverted_index., | 118, 196 |
| abstract_inverted_index.. | 130 |
| abstract_inverted_index.a | 11, 94, 233, 249 |
| abstract_inverted_index.as | 10, 141, 153 |
| abstract_inverted_index.by | 54, 155 |
| abstract_inverted_index.in | 35, 59, 67, 93, 103, 123, 125, 128, 151, 204, 213, 221, 238 |
| abstract_inverted_index.is | 7 |
| abstract_inverted_index.it | 23 |
| abstract_inverted_index.of | 33, 38, 82, 87, 100, 136, 181, 194, 218, 236 |
| abstract_inverted_index.to | 14, 25, 77, 189 |
| abstract_inverted_index.we | 29 |
| abstract_inverted_index.Key | 111 |
| abstract_inverted_index.Our | 230 |
| abstract_inverted_index.The | 3, 46 |
| abstract_inverted_index.and | 1, 42, 66, 120, 127, 132, 164, 168, 187, 191, 198, 216, 223, 228, 243 |
| abstract_inverted_index.for | 253 |
| abstract_inverted_index.p53 | 6, 34, 55, 64, 88, 114, 143, 237 |
| abstract_inverted_index.the | 31, 36, 79, 179 |
| abstract_inverted_index.was | 57, 75, 201, 211 |
| abstract_inverted_index.0.5% | 95 |
| abstract_inverted_index.Dual | 71 |
| abstract_inverted_index.acid | 40, 48, 163, 183, 220, 241 |
| abstract_inverted_index.bile | 39, 47, 104, 162, 182, 219, 240 |
| abstract_inverted_index.from | 185 |
| abstract_inverted_index.gall | 157 |
| abstract_inverted_index.gene | 50 |
| abstract_inverted_index.have | 20 |
| abstract_inverted_index.mice | 124, 215 |
| abstract_inverted_index.role | 32, 235 |
| abstract_inverted_index.that | 22, 176 |
| abstract_inverted_index.used | 76 |
| abstract_inverted_index.vivo | 129 |
| abstract_inverted_index.were | 91, 106, 139, 225 |
| abstract_inverted_index.with | 63 |
| abstract_inverted_index.ABCC3 | 131 |
| abstract_inverted_index.Here, | 28 |
| abstract_inverted_index.Trp53 | 68 |
| abstract_inverted_index.acids | 105 |
| abstract_inverted_index.assay | 74 |
| abstract_inverted_index.liver | 188 |
| abstract_inverted_index.mice, | 152 |
| abstract_inverted_index.mice. | 70, 206 |
| abstract_inverted_index.model | 99 |
| abstract_inverted_index.mouse | 60, 98 |
| abstract_inverted_index.novel | 234 |
| abstract_inverted_index.serum | 160, 186 |
| abstract_inverted_index.total | 161, 165 |
| abstract_inverted_index.using | 108 |
| abstract_inverted_index.vitro | 126 |
| abstract_inverted_index.which | 247 |
| abstract_inverted_index.(human | 134 |
| abstract_inverted_index.CYP2B6 | 133 |
| abstract_inverted_index.Cholic | 207 |
| abstract_inverted_index.Recent | 18 |
| abstract_inverted_index.cholic | 96, 148 |
| abstract_inverted_index.detect | 78 |
| abstract_inverted_index.direct | 142 |
| abstract_inverted_index.faeces | 224 |
| abstract_inverted_index.genes. | 84, 145 |
| abstract_inverted_index.genome | 16 |
| abstract_inverted_index.injury | 210 |
| abstract_inverted_index.levels | 167, 217 |
| abstract_inverted_index.target | 83, 144, 252 |
| abstract_inverted_index.tumour | 4 |
| abstract_inverted_index.Changes | 102 |
| abstract_inverted_index.Cyp2b10 | 117, 137, 195 |
| abstract_inverted_index.Purpose | 2 |
| abstract_inverted_index.Results | 112 |
| abstract_inverted_index.Sult2a1 | 119, 197 |
| abstract_inverted_index.effects | 86 |
| abstract_inverted_index.faeces. | 192 |
| abstract_inverted_index.further | 202 |
| abstract_inverted_index.induced | 116 |
| abstract_inverted_index.primary | 61 |
| abstract_inverted_index.profile | 52 |
| abstract_inverted_index.studies | 19 |
| abstract_inverted_index.suggest | 232 |
| abstract_inverted_index.‐null | 69 |
| abstract_inverted_index.Approach | 45 |
| abstract_inverted_index.Targeted | 172 |
| abstract_inverted_index.affected | 53 |
| abstract_inverted_index.alkaline | 169 |
| abstract_inverted_index.analysis | 174 |
| abstract_inverted_index.assessed | 58 |
| abstract_inverted_index.bladder, | 158 |
| abstract_inverted_index.enhanced | 178 |
| abstract_inverted_index.findings | 231 |
| abstract_inverted_index.molecule | 13 |
| abstract_inverted_index.preserve | 15 |
| abstract_inverted_index.provides | 248 |
| abstract_inverted_index.reporter | 73 |
| abstract_inverted_index.revealed | 175 |
| abstract_inverted_index.shrunken | 156 |
| abstract_inverted_index.Abcc2/3/4 | 121, 199 |
| abstract_inverted_index.activator | 89 |
| abstract_inverted_index.activity. | 171 |
| abstract_inverted_index.analysis. | 110 |
| abstract_inverted_index.bilirubin | 166 |
| abstract_inverted_index.confirmed | 203 |
| abstract_inverted_index.decreased | 159 |
| abstract_inverted_index.depletion | 65 |
| abstract_inverted_index.diseases. | 27 |
| abstract_inverted_index.evaluated | 107 |
| abstract_inverted_index.excretion | 180 |
| abstract_inverted_index.intestine | 190, 222 |
| abstract_inverted_index.metabolic | 26 |
| abstract_inverted_index.potential | 250 |
| abstract_inverted_index.promoting | 239 |
| abstract_inverted_index.syndrome, | 246 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.acid‐fed | 97 |
| abstract_inverted_index.activation | 56, 115 |
| abstract_inverted_index.activities | 81 |
| abstract_inverted_index.aggravated | 212 |
| abstract_inverted_index.attenuated | 147 |
| abstract_inverted_index.decreased. | 226 |
| abstract_inverted_index.expression | 51, 122, 200 |
| abstract_inverted_index.identified | 140 |
| abstract_inverted_index.integrity. | 17 |
| abstract_inverted_index.luciferase | 72 |
| abstract_inverted_index.orthologue | 135 |
| abstract_inverted_index.recognized | 9 |
| abstract_inverted_index.regulation | 37 |
| abstract_inverted_index.suppressor | 5 |
| abstract_inverted_index.Conclusions | 227 |
| abstract_inverted_index.Doxorubicin | 146 |
| abstract_inverted_index.alleviating | 244 |
| abstract_inverted_index.cholestasis | 150 |
| abstract_inverted_index.cholestatic | 205, 209, 245 |
| abstract_inverted_index.contributes | 24 |
| abstract_inverted_index.disposition | 41, 242 |
| abstract_inverted_index.doxorubicin | 90, 177 |
| abstract_inverted_index.hepatocytes | 62 |
| abstract_inverted_index.metabolites | 184 |
| abstract_inverted_index.phosphatase | 170 |
| abstract_inverted_index.therapeutic | 251 |
| abstract_inverted_index.Experimental | 44 |
| abstract_inverted_index.Implications | 229 |
| abstract_inverted_index.cholestasis. | 43, 101, 254 |
| abstract_inverted_index.demonstrated | 21, 154 |
| abstract_inverted_index.investigated | 30, 92 |
| abstract_inverted_index.metabolomics | 109, 173 |
| abstract_inverted_index.surveillance | 12 |
| abstract_inverted_index.traditionally | 8 |
| abstract_inverted_index.acid‐induced | 149, 208 |
| abstract_inverted_index.Anticholestatic | 85 |
| abstract_inverted_index.Up‐regulation | 193 |
| abstract_inverted_index.p53‐deficient | 214 |
| abstract_inverted_index.transcriptional | 80 |
| abstract_inverted_index.disposition‐related | 49 |
| abstract_inverted_index.Doxorubicin‐mediated | 113 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5100373743, https://openalex.org/A5100393441, https://openalex.org/A5100435226, https://openalex.org/A5056200578, https://openalex.org/A5100407704, https://openalex.org/A5068145080, https://openalex.org/A5088331911, https://openalex.org/A5015125917, https://openalex.org/A5100663357, https://openalex.org/A5083245275, https://openalex.org/A5100655503, https://openalex.org/A5062586202, https://openalex.org/A5020183416 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 13 |
| corresponding_institution_ids | https://openalex.org/I157773358, https://openalex.org/I4210128921 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.75 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.78650402 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |